Monday, November 18, 2024
HomeTagsNYPRG-101 Migraine

NYPRG-101 Migraine

Ceruvia Lifesciences Submits FDA Investigational New Drug Application for NYPRG-101 Migraine Prevention Program

Ceruvia Lifesciences, a leading neurotransformational medicine biopharmaceutical company today announced the submission of an IND application to begin a Phase 1, single center, randomized,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics